Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome

Background: Overexpression of the transsulfuration enzyme cystathionine-β-synthase (CBS), and overproduction of its product, hydrogen sulfide (H2S) are recognized as potential pathogenetic factors in Down syndrome (DS). The purpose of the study was to determine how the mitochondrial function and cor...

Full description

Bibliographic Details
Main Authors: Theodora Panagaki, Laszlo Pecze, Elisa B. Randi, Anni I. Nieminen, Csaba Szabo
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Redox Biology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213231722001884
_version_ 1798042475465539584
author Theodora Panagaki
Laszlo Pecze
Elisa B. Randi
Anni I. Nieminen
Csaba Szabo
author_facet Theodora Panagaki
Laszlo Pecze
Elisa B. Randi
Anni I. Nieminen
Csaba Szabo
author_sort Theodora Panagaki
collection DOAJ
description Background: Overexpression of the transsulfuration enzyme cystathionine-β-synthase (CBS), and overproduction of its product, hydrogen sulfide (H2S) are recognized as potential pathogenetic factors in Down syndrome (DS). The purpose of the study was to determine how the mitochondrial function and core metabolic pathways are affected by DS and how pharmacological inhibition of CBS affects these parameters. Methods: 8 human control and 8 human DS fibroblast cell lines have been subjected to bioenergetic and fluxomic and proteomic analysis with and without treatment with a pharmacological inhibitor of CBS. Results: DS cells exhibited a significantly higher CBS expression than control cells, and produced more H2S. They also exhibited suppressed mitochondrial electron transport and oxygen consumption and suppressed Complex IV activity, impaired cell proliferation and increased ROS generation. Inhibition of H2S biosynthesis with aminooxyacetic acid reduced cellular H2S, improved cellular bioenergetics, attenuated ROS and improved proliferation. 13C glucose fluxomic analysis revealed that DS cells exhibit a suppression of the Krebs cycle activity with a compensatory increase in glycolysis. CBS inhibition restored the flux from glycolysis to the Krebs cycle and reactivated oxidative phosphorylation. Proteomic analysis revealed no CBS-dependent alterations in the expression level of the enzymes involved in glycolysis, oxidative phosphorylation and the pentose phosphate pathway. DS was associated with the dysregulation of several components of the autophagy network; CBS inhibition normalized several of these parameters. Conclusions: Increased H2S generation in DS promotes pseudohypoxia and contributes to cellular metabolic dysfunction by causing a shift from oxidative phosphorylation to glycolysis.
first_indexed 2024-04-11T22:36:02Z
format Article
id doaj.art-b0becb51c84d4deebe6c55969415c4fb
institution Directory Open Access Journal
issn 2213-2317
language English
last_indexed 2024-04-11T22:36:02Z
publishDate 2022-09-01
publisher Elsevier
record_format Article
series Redox Biology
spelling doaj.art-b0becb51c84d4deebe6c55969415c4fb2022-12-22T03:59:12ZengElsevierRedox Biology2213-23172022-09-0155102416Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndromeTheodora Panagaki0Laszlo Pecze1Elisa B. Randi2Anni I. Nieminen3Csaba Szabo4Faculty of Science and Medicine, University of Fribourg, Fribourg, SwitzerlandFaculty of Science and Medicine, University of Fribourg, Fribourg, SwitzerlandFaculty of Science and Medicine, University of Fribourg, Fribourg, SwitzerlandMetabolomics Unit, Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, FinlandFaculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; Corresponding author. Faculty of Science and Medicine, University of Fribourg, Ch. du Musée 18, Fribourg, 1700, Switzerland.Background: Overexpression of the transsulfuration enzyme cystathionine-β-synthase (CBS), and overproduction of its product, hydrogen sulfide (H2S) are recognized as potential pathogenetic factors in Down syndrome (DS). The purpose of the study was to determine how the mitochondrial function and core metabolic pathways are affected by DS and how pharmacological inhibition of CBS affects these parameters. Methods: 8 human control and 8 human DS fibroblast cell lines have been subjected to bioenergetic and fluxomic and proteomic analysis with and without treatment with a pharmacological inhibitor of CBS. Results: DS cells exhibited a significantly higher CBS expression than control cells, and produced more H2S. They also exhibited suppressed mitochondrial electron transport and oxygen consumption and suppressed Complex IV activity, impaired cell proliferation and increased ROS generation. Inhibition of H2S biosynthesis with aminooxyacetic acid reduced cellular H2S, improved cellular bioenergetics, attenuated ROS and improved proliferation. 13C glucose fluxomic analysis revealed that DS cells exhibit a suppression of the Krebs cycle activity with a compensatory increase in glycolysis. CBS inhibition restored the flux from glycolysis to the Krebs cycle and reactivated oxidative phosphorylation. Proteomic analysis revealed no CBS-dependent alterations in the expression level of the enzymes involved in glycolysis, oxidative phosphorylation and the pentose phosphate pathway. DS was associated with the dysregulation of several components of the autophagy network; CBS inhibition normalized several of these parameters. Conclusions: Increased H2S generation in DS promotes pseudohypoxia and contributes to cellular metabolic dysfunction by causing a shift from oxidative phosphorylation to glycolysis.http://www.sciencedirect.com/science/article/pii/S2213231722001884Down syndromeMetabolismOxidative phosphorylationGlycolysisHydrogen sulfide
spellingShingle Theodora Panagaki
Laszlo Pecze
Elisa B. Randi
Anni I. Nieminen
Csaba Szabo
Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome
Redox Biology
Down syndrome
Metabolism
Oxidative phosphorylation
Glycolysis
Hydrogen sulfide
title Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome
title_full Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome
title_fullStr Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome
title_full_unstemmed Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome
title_short Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome
title_sort role of the cystathionine β synthase h2s pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome
topic Down syndrome
Metabolism
Oxidative phosphorylation
Glycolysis
Hydrogen sulfide
url http://www.sciencedirect.com/science/article/pii/S2213231722001884
work_keys_str_mv AT theodorapanagaki roleofthecystathioninebsynthaseh2spathwayinthedevelopmentofcellularmetabolicdysfunctionandpseudohypoxiaindownsyndrome
AT laszlopecze roleofthecystathioninebsynthaseh2spathwayinthedevelopmentofcellularmetabolicdysfunctionandpseudohypoxiaindownsyndrome
AT elisabrandi roleofthecystathioninebsynthaseh2spathwayinthedevelopmentofcellularmetabolicdysfunctionandpseudohypoxiaindownsyndrome
AT anniinieminen roleofthecystathioninebsynthaseh2spathwayinthedevelopmentofcellularmetabolicdysfunctionandpseudohypoxiaindownsyndrome
AT csabaszabo roleofthecystathioninebsynthaseh2spathwayinthedevelopmentofcellularmetabolicdysfunctionandpseudohypoxiaindownsyndrome